Jacobson Pharma Corporation

Jacobson Pharma Corporation EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Jacobson Pharma Corporation (2633.HK) as of Oct 15, 2026 is 353.18 M HKD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 414.60 M HKD — a change of -14.81% (lower).

EBITDA

353.18 MHKD

YoY

-14.81%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Jacobson Pharma Corporation is 2026 353.18 M HKD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Jacobson Pharma Corporation was 2025 414.60 M HKD. It decreases by -14.81% lower compared to the previous year.

The Jacobson Pharma Corporation EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
339.07 M HKD
Jan 1, 2020
295.44 M HKD
Jan 1, 2021
185.50 M HKD
Jan 1, 2022
222.89 M HKD
Jan 1, 2023
319.10 M HKD
Jan 1, 2024
333.13 M HKD
Jan 1, 2025
414.60 M HKD
Jan 1, 2026
353.18 M HKD
The Jacobson Pharma Corporation EBITDA history
YEAREBITDAYoY
353.18 MHKD-14.81%
414.60 MHKD+24.46%
333.13 MHKD+4.39%
319.10 MHKD+43.17%
222.89 MHKD+20.15%
185.50 MHKD-37.21%
295.44 MHKD-12.87%
339.07 MHKD+21.05%
280.11 MHKD+10.20%
254.19 MHKD+29.72%
195.96 MHKD+41.14%
138.84 MHKD-37.72%
222.92 MHKD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Jacobson Pharma Corporation Stock analysis

What does Jacobson Pharma Corporation do? Jacobson Pharma Corporation Ltd, listed on the Hong Kong Stock Exchange under ticker 2633.HK, is a pharmaceutical company operating in the Health Care sector. The company's ISIN is KYG677291067, and it is based in Hong Kong, though the specific city is unknown. Jacobson Pharma provides generic drugs for both public and private sectors, employing 1,789 full-time staff. The company went public via an IPO on September 21, 2016. Its business is structured into two segments: the Generic Drugs segment, which focuses on the development, manufacturing, and distribution of off-patent medicines for various therapeutic uses, and the Branded Healthcare segment, which develops, manufactures, and distributes branded medicines, proprietary Chinese medicines, and health and wellness products. Both segments primarily operate within Hong Kong. The company's website is http://www.jacobsonpharma.com/. Jacobson Pharma Corporation Ltd does not disclose additional details regarding its founding year, key executives, specific product names, or financial figures beyond the provided data. The company's operations are centered around pharmaceutical manufacturing and distribution, emphasizing generic and branded healthcare solutions in the Hong Kong market. Jacobson Pharma Corporation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jacobson Pharma Corporation stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Jacobson Pharma Corporation is 353.18 M HKD in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Jacobson Pharma Corporation changed from 414.60 M HKD to 353.18 M HKD, representing a -14.81% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Jacobson Pharma Corporation since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s HKD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Jacobson Pharma Corporation historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Jacobson Pharma Corporation

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Jacobson Pharma Corporation